Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03335800 · ClinicalTrials.gov registry record · NA

Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias

A NA study, sponsored by Apple.

Completed
Registry status
NA
Development phase
419,927
Enrollment target

NCT03335800: Completed NA study, sponsored by Apple.

NCT03335800 is a NA study that has completed, run by Apple. The registered enrollment target is 419,927 participants, above the 1,396-participant average among 58,714 other NA trials with a reported enrollment target (29981% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03335800, a NA study, has completed, sponsored by Apple.

COMPLETED
Registry status
NA
Development phase
419,927 participants
Enrollment target

Study Summary

The Apple Heart Study (AHS) is a research study conducted to evaluate whether the Apple Heart Study App can use data collected on the Apple Watch to identify irregular heart rhythms, including those from potentially serious heart conditions such as atrial fibrillation. Up to 500,000 can participate in the study.

Primary Outcome

Proportion of notified participants who received an irregular pulse notification and that had AF detected on the ambulatory ECG.

Interventions

  • DEVICE Apple Heart Study App

Trial Details

FieldValue
Enrollment Target 419,927 participants
Start Date 2017-11-29
Est. Completion 2019-02-21
Phase NA
Apple

12 total trials

What the finished NCT03335800 record still lists

NCT03335800 is an interventional study that assigns participants to a tested intervention. Its 419,927 participants enrollment target places it among the larger protocols in the corpus, above the 1,396-participant average among 58,714 other NA trials with a reported enrollment target (29981% higher).

The record links to 0 conditions, and to 1 intervention - of which Apple Heart Study App is the first listed.

NCT03335800 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03335800 about?

NCT03335800 is a clinical study titled "Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias". The Apple Heart Study (AHS) is a research study conducted to evaluate whether the Apple Heart Study App can use data collected on the Apple Watch to identify irregular heart rhythms, including those from potentially serious heart conditions such as atrial fibrillation. Up to 500,000 can participate ...

What is the current status of trial NCT03335800?

This trial is currently completed. It is a NA study. The enrollment target is 419,927 participants. The study started on 2017-11-29. Estimated completion is 2019-02-21.

What interventions are being tested in trial NCT03335800?

The interventions under investigation include: Apple Heart Study App (DEVICE).

Who is sponsoring clinical trial NCT03335800?

This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03335800's enrollment target sits among peer trials

419,927 1st of 2000 higher than 2,000 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06342375 · 425,000 participants · NA

    Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage

  • NCT06934239 · 400,000 participants · Phase 4

    A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

  • NCT05065060 · 500,000 participants

    Parkinson Progression Marker Initiative Online (PPMI Online)

  • NCT06017687 · 500,000 participants · NA

    Data Collection and Evaluation of OptiBP Under Investigational Use

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03335800, the US trial registry maintained by the National Library of Medicine. NCT03335800 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.